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Abstract
Background: Onychomycosis is a highly prevalent nail infective disorder. Many treatments, with varied success rates and side
effects, are used.
Objectives:To assess the most recommended treatment for Onychomycosis with the optimal cure rate and least severe side effects.
Search Methods: PubMed, ProQuest, EBSCO Multisearch, and Google Scholar were used to gather information. Search terms such
as “Onychomycosis,” and “Effective treatments for Onychomycosis” etc. were used.
Results: Effective treatments include oral, topical, nail avulsion, and laser treatments. Topical treatments have low cure rates and
minimal side effects. Oral treatments have various side effects but the highest mycological and clinical cure rates. Laser treatments
yield high cure rates and minimal to none side effects, but a small chance of recurrence of the Onychomycosis is possible.
Conclusion: For those who are not susceptible to adverse effects, Oral treatment is the recommended treatment. For individuals
who have pre-existing conditions that may be harmed by adverse effects of medication, Laser should be the sought treatment.
Topical treatments are not recommended due to its low efficacy rate.
Introduction
Onychomycosis, fungal infection, is the most ubiquitous
nail infective disorder with a prevalence in males and elderly individuals. It is accountable for almost half of nail
disorder consultations. Although traditionally harmless,
Onychomycosis, if left untreated, can occasionally lead
to more serious complications, especially in individuals
with pre-disposing factors, such as diabetes, HIV- induced immunosuppression, and arterial disease (Piraccini,
Alessandrini, 2015). Various researched treatments with
high success rates are used to treat fungal nail infections.
The Success of treatments is weighed by the clinical cure,
which refers to the decreased deformity or discoloration of the nail, and mycological cure, which refers to
the absence of fungus within the nail (Kreijkamp-Kaspers,
Hawke, 2017). This study seeks to determine what is the
most recommended treatment for Onychomycosis.
There are several forms of
Onychomycosis. Distal and Lateral
Lateral
Subungual Onychomycosis (DLSO) is Distal
Subungual
caused by fungus infecting the distal Onychomycosis
or lateral area of the nail (Kreijkamp- (DLSO)
Kaspers, Hawke, 2017). It is charac- Superficial
terized by a yellow-white detached Onychomycosis (SO)
nail plate and hardening of the skin, Endonyx
also known as hyperkeratosis. It is Onychomycosis (EO)
Subungual
often associated with athletes’ foot, Proximal
Onychomycosis (PSO)
and occasional brown, black, or orange discoloration (Figure 1). A detached nail from the nail bed or white
streaks on the nail are also common
(Kreijkamp-Kaspers, Hawke, 2017). Mixed Pattern
Onychomycosis
Superficial Onychomycosis (SO) oc- (MPO)
curs when fungus enters the nail plate Total Dystrophic
and forms white opaque colonies in Onychomycosis
the form of raised grooves that can (TDO)
be easily rubbed off (Figure 2). This

form of Onychomycosis is also often associated with
athlete’s foot. The most basic form of SO happens because of dermatophytes colonizing the outer layers of
the nail without penetrating it. Endonyx Onychomycosis
(EO) occurs when the fungal hyphae in the distal nail
plate is permeated by fungus. The nail appears to be split
in half lengthwise with possible discoloration (Figure 3)
(Kreijkamp-Kaspers, Hawke, 2017). Proximal Subungual
Onychomycosis (PSO) is caused by fungus originating
in the proximal nail fold and spreading to the upper
portion of the nail (Kreijkamp-Kaspers, Hawke, 2017).
It causes a white area to appear under the lunula area
of the nail along with periungual inflammation. It also
causes bacterial paronychia and nail pustular psoriasis
(Figure 4) (Piraccini, Alessandrini, 2015). Mixed Pattern
Onychomycosis (MPO) occurs when different forms
of Onychomycosis are present in the same patient, and

Fungal Location

Toe/Nail Features

Distal or lateral area of
the nail is infected

Hyperkeratosis
Discoloration of the nail
Onycholysis
Streaking

Nail surface is infected but
the surrounding area is not

Striae on the nail

Fungus permeates the
fungal hyphae of the nail

Nail split lengthwise
Discolored nail

Originates in the proximal
nail and spreads upward

White area appears under
the lunula area of the nail
Periungual inflammation
Bacterial paronychia
Nail pustular psoriasis

Different forms of onychomycosis occur in the same person,
possibly in the same nail

Features associated with whichever
form of onychomycosis is present

Occurring following other forms Crumbled nail
of onychomycosis, it is caused
Thick and ridged nailbed
by different organisms entering
the nail plate
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possibly even in the same nail. The final form of fungal
nail infection is Total Dystrophic Onychomycosis (TDO),
which follows other forms of Onychomycosis and is characterized by a crumbled nail with a thickened nail bed
(Figure 5) (Kreijkamp-Kaspers, Hawke, 2017)

Methods
PubMed, ProQuest, Ebsco Multisearch, and Google
Scholar were used to extract information. Terms such
as “Onychomycosis” and “Effective Treatment for
Onychomycosis” etc. were used.

Figure 1
Distal Lateral Subungual Onychomycosis (DLSO). It is characterized by
a yellow-white detached nail plate and hardening of the skin, also known
as hyperkeratosis. It is often associated with discoloration of the nail and
white streaks on the nailbed (Kreijkamp-Kaspers, Hawke, 2017).

Figure 2
Superficial Onychomycosis occurs when fungus enters the nail plate and
forms white opaque colonies in the form of raised grooves that can be
easily rubbed off (Kreijkamp-Kaspers, Hawke, 2017)..

Figure 3
Endonyx Onychomycosis- the nail appears to be split in half lengthwise
with possible discoloration (Kreijkamp-Kaspers, Hawke, 2017)

Figure 4
Proximal Subungual Onychomycosis causes a white area to appear under
the lunula area of the nail along with periungual inflammation. It also causes bacterial paronychia and nail pustular psoriasis (Piraccini, Alessandrini,
2015).

Figure 5
Total Dystrophic Onychomycosis is characterized by a crumbled nail with
a thickened nail bed (Kreijkamp-Kaspers, Hawke, 2017).
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Effective Treatments for Onychomycosis

Oral Treatment
One method currently used in treating fungal nails is
an oral medication. The three most common ones prescribed are griseofulvin, terbinafine, and azoles.The drawback of this treatment method is that oral medications
generally require long treatment periods and can cause
various side effects. Because oral drugs can cause liver
damage, patients must first undergo a liver function test
to begin this form of treatment. Medication can be classified as fungistatic (inhibiting the growth of fungal cells), or
fungicidal (directly causing cell death)(Kreijkamp-Kaspers,
Hawke, 2017).
Griseofulvin, a fungistatic drug, was the first oral medication created to treat Onychomycosis. It disrupts the
cell microtubules and is effective in fighting dermatophytes but ineffective at fighting yeast. The response rate
of this drug is poor. Common side effects associated with
Griseofulvin are allergic reactions, stomach disturbance,
and nausea (Kreijkamp-Kaspers, Hawke, 2017).
The Azoles are a fungistatic class of medications.
Common ones include Itraconazole and Ketoconazole,
and they are given over the course of a few months. The
growth of the fungus is halted by suppressing the synthesis of ergosterol in the cell membrane via the CYP51A1
enzyme. Side effects of the Azoles include nausea, bloating, diarrhea, and liver damage (Shirwaikar et. al. 2008).
Terbinafine, an allylamine drug, is the most recent oral
medication created to treat Onychomycosis.As a fungicidal
treatment, it acts as a non-competitive inhibitor for Squalene
Epoxidase, the enzyme responsible for the conversion of
Squalene to Eroserol in the fungal membrane. This causes
toxic levels of Squalene that make holes in the membrane,
eventually killing the fungus (Kreijkamp-Kaspers, Hawke,
2017). Terbinafine requires an 8–12-week daily dose and
can cause headaches and diarrhea (Shirwaikar et. al. 2008).
Terbinafine has been demonstrated multiple times to be
the most effective oral medication with the least severe
side effects (Kreijkamp-Kaspers, Hawke, 2017).

To determine the effects of oral treatment, a randomized double- blind study was done contrasting two oral
medications, terbinafine and itraconazole. The Terbinafine
group, consisting of 186 patients, received a daily dose of
250 mg/day for 12 weeks, while the itraconazole group,
also consisting of 186 patients, received 200 mg/day for
12 weeks. Clinical and mycological cures were assessed at
weeks 4, 8, 12, 24, 36, and 48. At 48 weeks, negative mycology was achieved by 73% of patients in the Terbinafine
group and 45.8% in the Itraconazole group. Clinical cures
were attained by 76.2% in the Terbinafine group and
58.1% in the Itraconazole group (De Backer Et al, 1998).
Based on this study, the oral treatment seems to be an
effective cure for Onychomycosis as the rates of mycological cure and clinical cure are high. Of the three most
common ones,Terbinafine is the most recommended due
to its efficacy and lack of side effects, but the Azoles and
Griseofulvin have a high cure rate as well. Oral medication
may be safest with younger children, as the older population is often on other medications and drug-drug interactions may occur (Leung et. el., 2020). Additionally, because
adverse effects of medication are common amongst the
immunosuppressed population, who are prone to onychomycosis, oral treatments should be avoided to ensure
an effective and safe treatment.
Topical Treatment
Another method used to treat fungal nail is topical therapy. Because toenails are generally non permeable, creams
are not always effective because they are unable to get
through the nail. Examples of commonly used creams
include Efinaconazole and Tavaborole. A new topical
method using nail lacquer has been recently introduced.
The nail lacquers contain chemicals that aid the penetration of the nail and allow for more effective healing. The
two main types of nail lacquers currently approved are
ciclopirox and amorolfine. Ciclopirox lacquers disrupt
the breakdown of toxic peroxides and the production of

Classification

Method of Fungal

Side Effects

Griseofulvin

Fungistatic

Disrupts cell
microtubules

Allergic reactions, stomach disturbance, and
nausea

Azoles

Fungistatic

The synthesis of
ergosterol is
suppressed by
CYP51A1 inhibition

Nausea, bloating,
diarrhea, and liver damage

Terbinafine

Fungicidal

The synthesis of
ergosterol is suppressed by
squalene epoxidase inhibition

Headaches and
Diarrhea
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intracellular energy. It may also prevent nutrient uptake of
the fungus which leads to fungal nutrient uptake resulting
in exhaustion of amino acids and a reduction in protein
synthesis. Side effects include rashes, nail irritation, discoloration, and ingrown toenail. On the other hand, an
Amorolfine lacquer leads to cell death by inhibiting sterol
biosynthesis. It is known to fight various forms of yeast,
molds, and dermophytes. After the amorolfine is applied
to the nail, it rests on the nail for seven days and slowly
penetrates the nail to reach the nail bed and heal the
fungal infection. This treatment requires constant application until the fungus is completely removed, which averages nine to 12 months for toenails. Side effects, though
rare, include itching, burning, inflammation, and irritation
(Shirwaikar et. al. 2008).
To assess the efficacy of topical treatments, a research
study measured the success rate of efinaconazole, a topical antifungal treatment. There were 62 patients, ages six
through 16 years, in the study. The cream was administered once a day for 48 weeks, and patients were re-evaluated at 4 weeks post-treatment. At 12 weeks following
the onset of treatment, 36.7 % of patients received a
complete mycologic cure, and 65.0% reached a complete
cure by the post-treatment follow-up (Eichenfield et. al.
2020).
To determine the efficacy of topical treatment, a 36week sequential treatment of chemical nail avulsion,
RV104A ointment, Ciclopirox cream, and Ciclopirox
nail lacquer was compared with a 36-week treatment
of Amorolfine. At 48 weeks, the mycological cure rate
was 36.6% for the combination treatment and 12.7% for
the amorolfine treatment. Clinical cure at week 48 was
achieved by 53.5% of the patients in the sequential treatment group and 17% in the nail lacquer group (Paul et.
al., 2013).
Topical treatments such as creams and nail lacquers do
not appear to be effective treatments for onychomycosis.
Low cure and clinical rates are associated with these interventions, and it relies heavily on the patient to comply
with directions and remember instructions.
Nail Avulsion Treatment
Nail avulsion, another treatment for Onychomycosis, involves removing part of the nail to access the infection
site and treating the root, along with the nearby tissues
with topical therapy. Chemical avulsion and surgical avulsion are two versions of this treatment. While surgical
avulsion is more painful and is prone to risks such as hematomas and nail distortions, chemical avulsion is a highly
tedious process.These treatments have high relapse rates
and poor patient compliance, so they are generally not
24

performed unless other treatments have failed (Nayak,
2021).
Forty patients were treated for onychomycosis using
a combined treatment of nail avulsion and topical therapy. Following the removal of the fungal nail, or part of
it, the creams were to be applied daily. There were many
dropouts or cases of non-compliance in the study, but 15
(56%) of the 27 remaining patients received a complete
cure. On a follow-up visit, recurrence was noted on two
patients. No side effects were noted in the study (Grover
et. al, 2007).
This study confirms prior research which suggests that
nail avulsion is not an effective treatment for onychomycosis. A low cure rate is associated with this method of
treatment, and painful side effects are common.
Device-Based Treatments
Device-based therapies are non-invasive treatments for
Onychomycosis that have high success rates. One such
treatment is Iontophoresis, which applies a current and
a charged drug to the infected nail bed. The flux rate of
the drug administered is controlled by the device, and this
treatment is sought after because of its high rate of nail
permeability. Another example of a device-based therapy
is ultrasound, which uses soundwaves to deliver drugs to
the infection. This also has a successful rate of permeability. Photodynamic therapy is a recent device-based therapy that has been introduced. It involves the excitation of
photosensitizing agents which create singlet oxygen that
is responsible for the death of fungal cells. Aminolevulinic
acid and methyl ester are two photosensitizing agents
used for this process (Nayak, 2021).
Laser therapy, another device-based treatment, was
developed using the principle of photothermolysis by targeting tissue in a designated area. A device sends a pulse
of radiation to the infected area and kills the fungi. There
are a few drawbacks of laser therapy, for example possible
damage to the tissue if used at an extreme level. Laser
therapy can also decrease collagen production, which
provides structure in the tissue (Kushwaha et. al. 2015).
Finally, the devices used for laser therapy are very expensive and are not covered by many insurances (Liddell,
Rosen, 2015). There are several types of FDA-approved
laser treatments utilized by podiatrists today.
The efficacy of laser treatment is dependent on several
factors. Firstly, the wavelength of the light must be capable of penetrating many layers, such as the nail plate and
underlying tissues. Therefore, the near-infrared spectrum
is used in laser treatments as this light is found to be
the most piercing. The pulse duration is another factor
that affects the treatment. The span of the pulse must
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be less than the thermal relaxation time of the target
(the infection), which requires the laser systems to use
relatively short pulse systems. The success of the laser
is also dependent on the repetition rate of the system,
which refers to the rate of the delivery of the pulses. A
higher repetition rate allows for an increased pulse rate,
which can speed up the treatment process. The diameter
of the laser beam, known as the spot size, varies in length
from 1mm to1 10mm, and the size of the beam has different effects on the treatment. A smaller size beam will
likely cause the laser to reach a greater surface area while
the larger beams may speed up the treatment time. The
fluence, which refers to the amount of energy pulsed into
the target area, is the final factor affecting the laser treatment and it is generally an average calculated by the spot
size and maximum pulse energy allowed (Gupta, Simpson,
2012).
There are several types of FDA-approved laser treatments utilized by podiatrists today. A long pulse laser system delivers long pulses to the infected area. The Fotona
Dualis system is a long pulse laser system. In a clinical
trial of this laser, 162 participants with confirmed onychomycosis were treated once a week for four consecutive
weeks. At the follow up visits, which ranged from 12-18
months post-treatment, 100% of participants achieved
mycological cures, and 93.5% reached clinical cures
(Gupta, Simpson, 2012).
A short-pulse laser system is another form of laser
treatment that delivers laser by the microsecond. The
Pin-Pointe FootLaser, GenesisPlus, VARIA, and JOULE
ClearSense are all examples that are on the market.
There have been many studies done on these systems,
which all yielded above 70% improvement of fungal nail.
(Gupta, Simpson, 2012).
A study on short-pulse laser divided 21 subjects with
Onychomycosis into three groups: 1319 nm laser light,
1064 nm laser light, and broadband light. Four treatments
spaced one week apart were given, and cultures were
taken at one, three, and six-months following treatment.
Patients reported mild to moderate discomfort and no
unpleasant effects occurred. Determined by the sixmonth culture, 20 of the 21 patients reached mycological
cure (Waibel et. al. 2013). This study may be confounded
due to bias because an author of the study expressed, via
a disclosure, a benefit in the production and usage of the
specific laser used in the study (Lidell, Rosen, 2015).
Long-pulse and short-pulse lasers were compared in
a trial consisting of 10 toenails with Onychomycosis.
Cultures were taken prior to treatment and at the ninemonth follow-up, and two independent evaluators rated
the fungus using the Onychomycosis Severity Index (OSI).

Patients were also ordered to apply Ciclopirox daily to
the infected area. Results showed no significant difference
between the different laser systems and the lowest OSI
level was seen at six months (Hees et. al. 2014).This study
suggests a recurrence of the fungus at nine months.
The final form of laser systems used by current medical
professionals is the Diode-laser system. This method can
be done in a range of wavelengths and uses a semiconductor to deliver laser beams. The Noveon Laser uses a
diode system and provides options of 870 and 930 nm
(Gupta, Simpson, 2012). A clinical trial was performed
on this system and measured the improvement of fungal
nail in 26 infected toes. Treatment was administered on
days 1, 14, 42, and 120, and follow up occurred on day
180. Results indicated that 85% of participants showed
a decreased infection area, 65% displayed 3mm of clear
nail growth, and 4 mm of clear nail growth was seen on
26% of the toes. This study provides objective proof of
the improvement of the toenails, but the sample size is
relatively small (Landsman et. al. 2010).
Jefferson et al., conducted a study that found diode
laser therapy to be effective with little or no side effects.
This study took samples of toenails from 3 independent
clinical trials that used a dual-diode laser system. Results
indicated that 67% of the toenails experienced more than
3mm of clear nail growth following the laser treatment,
and 89% had increased clear nail growth at the six month
follow up. No side effects were noted in any of the patients (Zang et. al. 2017).
Laser therapy demonstrates high cure rates for
Onychomycosis. While all forms yield successful results,
the long pulse laser seems to be the most effective in
treating fungal nail. Although recurrence is a small possibility, laser treatment may be suggestable for patients
with pre-existing conditions who cannot undergo other
forms of Onychomycosis treatment due to its limited
side effects.
Discussion
Onychomycosis is a prevalent nail disorder affecting many
people daily. While various forms of treatment are used,
their treatment lengths, cure rates, and side effects must
be taken into account. Topical remedies such as ointments and lacquers do not achieve clinically significant
cure rates. Nail avulsion is a painful process and does not
have a high efficacy. Oral treatments have the highest cure
rate, but the common side effects prevent many people
from using this treatment. For those without pre-existing
conditions whose safety will not be compromised by its
use, oral medication is the optimal course of treatment.
Laser therapy, because of its high cure rate and lack of
25
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side effects, is recommended as the gold standard of
treatment for Onychomycosis for those who cannot tolerate the adverse effects of oral medications.
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